BioSpace News Archive

Brian Wong, M.D., Ph.D., CEO will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 7:30 a.m. Pacific Standard Time in San Francisco, CA.

SOL Global will acquire a 25 percent stake in the equity of GreenLight for €1.8 million, with an option to increase its stake to 51 percent.

Technavio analysts forecast the global respiratory drugs market to grow at a CAGR of close to 6% during the forecast period, according to their latest market research report.

Intensive Weight-Loss and Lifestyle-Change Program Now Available in Digital Format

Just in time for the New Year, rankings offer Best Overall Diets, Best Diets for Weight Loss and more across over 40 diet plans.

Dr. Lamelas to become UHealth’s new Chief of Cardiothoracic Surgery

ORHub, Inc. (OTC: ORHB) (the “Company” or “ORHub”), a SaaS-based healthcare data analytics company uniquely focused on the business of surgery to improve the profitability of health systems, hospitals and ambulatory surgery centers (ASCs), today announces that ORHub has signed an agreement with a new ambulatory surgery center in Arkansas.

Myonexus Therapeutics, announced today that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation for MYO-102, a novel gene therapy candidate for alpha-sarcoglycanopathy, also known as Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)

Initial data shows HPN424 serum exposure supports weekly dosing Changes in blood-derived tumor cell and serum biomarkers consistent with T cell activation HPN424 dose escalation proceeding to identify Phase 2 therapeutic dose

The acquisition is intended to help accelerate the growth of Neogen’s animal genomics business throughout Canada.